ANTISPASMODIC, DIURETIC AND ANTI-INFLAMMATORY DRUG (VERSIONS) Russian patent published in 2025 - IPC A61K36/74 A61K36/81 A61K36/61 A61K36/23 A61K36/235 A61P7/10 A61P13/04 A61P13/06 A61P29/00 

FIELD: pharmaceutics.

SUBSTANCE: group of inventions refers to pharmaceutical industry, namely to antispasmodic, diuretic and anti-inflammatory agents. Antispasmodic, diuretic and anti-inflammatory drug containing: common madder tincture, magnesium salicylate, mixture of essential oils with a set of biologically active substances, salicylic acid, linoleic and linolenic acids, ethanol and castor oil, wherein agent contains as essential oils – eucalyptus essential oil, aniseed essential oil and fennel essential oil, and as biologically active substances – fenchone and D-limonene of fennel essential oil in amount of 0.2950 g and 0.1475 g, respectively, per 10 ml of the agent, at the following content of ingredients per 10 ml of the agent: common madder extract dry (content of total anthraglycosides in terms of ruberythric acid is not less than 8.0%) 0.0093 g; magnesium salicylate 0.1400 g; eucalyptus essential oil 2.8000 g; aniseed essential oil 1.4750 g; fennel essential oil 1.4750 g; anhydrous ethanol 0.7500 g; salicylic acid 0.0200 g; linoleic acid 0.7000 g; linolenic acid 0.7000 g; castor oil up to 10.00 ml. An antispasmodic, diuretic and anti-inflammatory drug containing: belladonna alkaloids, common madder tincture, magnesium salicylate, mixture of essential oils with a set of biologically active substances, salicylic acid, linoleic and linolenic acids, ethanol and castor oil, wherein the agent contains as belladonna alkaloids the sum of belladonna alkaloids, converted to hyoscyamine, as essential oils – eucalyptus essential oil, aniseed essential oil and fennel essential oil, and as biologically active substances – fenchone and D-limonene of fennel essential oil in amount of 0.2950 g and 0.1475 g, respectively, per 10 ml of the agent, at the following content of ingredients per 10 ml of the agent: sum of belladonna alkaloids in terms of hyoscyamine 0.0025 g; common madder extract dry (content of total anthraglycosides in terms of ruberythric acid is not less than 8.0%) 0.0093 g; magnesium salicylate 0.1400 g; eucalyptus essential oil 2.8000 g; aniseed essential oil 1.4750 g; fennel essential oil 1.4750 g; anhydrous ethanol 0.7500 g; salicylic acid 0.0200 g; linoleic acid 0.7000 g; linolenic acid 0.7000 g; castor oil up to 10.00 ml.

EFFECT: above described agents provide more pronounced antispasmodic, diuretic effects, as well as anti-inflammatory effect in the form of prevention of bladder inflammation in contact with a bacterial agent.

2 cl